Related Experiment Videos
[Increased activation of CD8-positive lymphocytes in patients with Crohn's disease]
1III. Medizinische Klinik und Poliklinik, Justus-Liebig-Universität Giessen.
Insights
This study found increased CD8+ T cells in Crohn's disease patients, indicating heightened immune cell activation. These CD8+ T cell changes are not unique to Crohn's disease and also appear in rheumatoid arthritis.
Area of Science:
- Immunology
- Cell Biology
- Gastroenterology
Background:
- Crohn's disease is an inflammatory bowel disease with complex immune system dysregulation.
- CD8+ T lymphocytes play a crucial role in immune responses and their alterations are implicated in autoimmune conditions.
Purpose of the Study:
- To investigate CD8+ T lymphocyte subpopulations in patients with Crohn's disease.
- To determine if specific CD8+ T cell subsets correlate with disease activity or clinical subsets.
- To assess soluble CD8 antigen levels in serum and their association with disease markers.
Main Methods:
- Flow cytometry analysis of peripheral blood CD8+ T lymphocyte subsets (CD57+, DR+, CD45RO+).
- Enzyme immunoassay to measure soluble CD8 antigen levels in patient sera.
- Correlation analysis with clinical data and erythrocyte sedimentation rate (ESR).
Main Results:
- Increased numbers of CD8+CD57+ T cells were observed in Crohn's disease patients compared to controls.
- Elevated levels of CD8+DR+ and CD8+CD45RO+ cells were found in a substantial number of patients.
- Significantly elevated soluble CD8 antigen levels were detected in sera, correlating with ESR values.
- Similar CD8+ T cell alterations were noted in patients with rheumatoid arthritis, another inflammatory condition.
Conclusions:
- The data suggest increased activation of CD8+ T lymphocytes in Crohn's disease, potentially linked to systemic disease activity.
- These CD8+ T cell disturbances are not specific to Crohn's disease and may reflect a broader immune response in inflammatory conditions.
Abstract:
CD8+ (suppressor/cytotoxic) T lymphocyte subpopulations were studied in the peripheral blood of patients with Crohn's disease by flow cytometry analysis. Consistent with earlier reports, increased numbers of CD8+CD57+ cells were observed as compared with controls. However, expanded CD8+CD57+ cells were not found to be present in a distinct clinical subset of patients. A substantial number of patients had enhanced numbers of DR+ and CD45RO CD8+ cells. In addition, high numbers of CD8+ cells which were CD57CD45RO double positive, and a correlation between numbers of CD8+CD57+ and CD8+DR+ lymphocytes were detected. By use of an enzyme immunoassay, significantly elevated levels of soluble CD8 antigen were demonstrated in patients' sera, and results were associated with ESR values. Taken together, the data suggest increased activation of CD8+ lymphocytes which might result from systemic disease activity. Disturbances within CD8+ lymphocytes do not seem to be specific to Crohn's disease since similar alterations could be observed in patients with another inflammatory condition, rheumatoid arthritis.